Why the study?
Does the concentration of collagen and initial platelet sensitivity affect the measurement of aspirin-induced inhibition of platelet aggregation in normal subjects?
Does the concentration of collagen and initial platelet sensitivity affect the measurement of aspirin-induced inhibition of platelet aggregation in normal subjects?
The ability to detect aspirin-induced inhibition of platelet aggregation depends on the concentration of collagen used and the baseline sensitivity of the platelets to collagen.
Answers are grounded in this paper and cite their sources.
Assay conditions for detecting ASA platelet inhibition must account for collagen concentration and baseline sensitivity; leaves open standardization for human testing.
Soluble collagen was extracted from human skin. The solutions of this collagen were storage-stable, and, in some samples of platelet-rich plasma, induced aggregation when diluted up to 1,000-fold. An examination of platelet aggregation in 20 normal subjects revealed a broad range of platelet responsiveness to collagen, as defined by the least collagen concentration needed to initiate platelet aggregation. The inhibitory effects of acetylsalicylic acid (ASA) were evaluated both in vitro and in vivo. There was a direct correlation between the collagen concentration needed to demonstrate ASA inhibition of platelet aggregation and initial platelet sensitivity to collagen. ASA inhibition was obscured if too-large collagen concentrations were used to study the aggregation of collagen-sensitive platelets. The quantitative relationships between collagen, ASA, and platelets have an important bearing on the estimation of ASA as a platelet antiaggregating agent.
No takes yet. Share an insight, caveat, or question.
Green et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: